Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE
about
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cellsAGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptorRestriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.Role of advanced glycation end products in cardiovascular disease.Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.Uremic Toxicity of Advanced Glycation End Products in CKD.Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.AGE restriction in diabetes mellitus: a paradigm shift.Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly personsAdvanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.Advanced glycation endproducts: from precursors to RAGE: round and round we go.Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epitheliumIncreased liver AGEs induce hepatic injury mediated through an OST48 pathway.Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence.AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.
P2860
Q24563997-4923FAEA-DBE3-4739-A3A6-501A7647B257Q33727690-1A805A0C-9A52-4499-A083-278F28982051Q34557348-23360D8D-3953-4FCA-A62E-2CAFF5162743Q35025205-6D0B6A90-F30D-4A37-AF09-734744C0B648Q35060239-58BB6BCA-65FA-4AB7-A54E-688C0F17DFC9Q35855642-E1BD08CE-6776-42A4-8B3E-07C675D5D450Q35929112-01164A60-0262-4687-92BC-EEAEF385C05BQ36300685-EFF7D0E2-5697-44C4-B018-EF47CF02C21AQ36514906-D99EE631-7A0C-41D3-AB6E-8C290059EF1AQ36796216-510337A7-B821-4F6C-9E0E-DB8488520241Q37003623-474B538C-E51E-46B6-B0A6-1F575241C8B2Q37214116-19E73BFD-B61A-4B4A-8D39-281259657B02Q37362121-D67BAC1B-DC88-4E38-9FF9-3CDB2B841A1BQ37417494-8EB26648-8F82-4C2D-B899-4B0E235BCF0FQ37801314-D3049A3D-C563-435D-A774-F3D68CBA4BBBQ38006722-BCC5B93E-AA85-4D0E-BC25-9683D48BF000Q40477757-0ABD62BD-43C6-4C92-AC97-E525B09B3FEAQ42061964-2910E6C1-C612-47E8-AFDD-6EB8B15CD817Q42120056-7DEED58F-B36C-4979-8364-7D699EC64394Q51747235-C2AA28C7-72A6-41D3-A1CA-479D6BF96DC4
P2860
Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@ast
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@en
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@nl
type
label
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@ast
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@en
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@nl
prefLabel
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@ast
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@en
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@nl
P2093
P1433
P1476
Presence of diabetic complicat ...... eptor-1 and elevated serum AGE
@en
P2093
P304
P407
P577
2001-03-01T00:00:00Z